Clinically Apparent Atrial Fibrillation Increases Stroke Risk; Does Subclinical AFib Do the Same?

Published Online: Tuesday, January 14, 2014
Stuart J. Connelly, MD, one of the principal authors of “Subclinical Atrial Fibrillation and the Risk of Stroke,” published in the New England Journal of Medicine, talks about the study.  

To listen to the podcast, click here.
Related Articles
Researchers evaluated more than 2 decades of evidence on atrial fibrillation patients taking vitamin K antagonists.
Researchers evaluated the risk of cardiovascular outcomes in atrial fibrillation patients with a history of falls.
An FDA report concludes that aspirin’s risks may outweigh its benefits in patients who do not have a history of cardiovascular problems.
Latest Issues
$auto_registration$